Allgemein
15. May 2025 / 15. May 2025 by fass_wp_ad_hk_52
The FASS Consortium is excited to take part in this year’s SLAS Europe conference Poster Presentation Catch Robert Harmel from EU-OPENSCREEN at our Poster to hear more about our work. Let’s connect and chat about FASS technology—whether you’re interested in a demo, want to collaborate, or have samples you’d like us to measure! Innovation Spotlight Our […]
Read more »
9. May 2025 / 9. May 2025 by fass_wp_ad_hk_52
Nathan Dupertuis (founder) comments:: I am looking forward to exhibit in the Innovation AveNEW corner at SLASEurope2025 in Hamburg, Germany organised by SLAS (Society for Laboratory Automation and Screening)! We will be just next our friends from PHABIOC. Come find us in the exhibition on May 21st and 22nd to learn more about Oryl Photonics’ […]
2. May 2025 / 9. May 2025 by fass_wp_ad_hk_52
Oryl Photonics and WP3 Bringing cutting-edge research to the pharmaceutical industry requires more than innovation—it demands a clear path to commercialization. In WP3, we focus on business development, ensuring that the FASS instrument not only meets scientific needs but is also market-ready. Our efforts include: Leading this effort is Oryl Photonics, an innovative technology company […]
17. April 2025 / 24. April 2025 by fass_wp_ad_hk_52
We’re excited to promote FASS at the Helmholtz Drug Discovery Conference between 28-30 April 2025 in Berlin! FASS offers a disruptive solubility measurement for Drug Discovery – fast, accurate, and highly sensitive measurements designed for the needs of pharmaceutical and chemical industries. Curious about how we’re redefining solubility measurements? Come find Robert Harmel and Yasemin […]
20. March 2025 / 25. April 2025 by fass_wp_ad_hk_52
Actions of EU-OPENSCREEN How do we transform innovative ideas into market-ready instruments? In WP1, our focus is on developing a THow do we ensure groundbreaking technology meets the needs of its future users? In WP2, the focus is on customer development—validating the value proposition of the FASS instrument and preparing it for market success. Here’s […]
4. March 2025 / 25. April 2025 by fass_wp_ad_hk_52
ALPhANOV in Action How do we transform innovative ideas into market-ready instruments? In WP1, our focus is on developing a TRL 6 demonstrator system that combines cutting-edge performance with reliability and ease of use. Here’s where ALPhANOV, a leader in laser and optical technologies, plays a critical role. With their expertise in 3D design, electronics, […]
25. September 2024 / 25. September 2024 by fass_wp_ad_hk_52
Postdoc in Novel Drug Solubility Analytics (80-90%) Our consortium member Prof. Martin Kuentz from Fachhochschule Nordwestschweiz FHNW has opened a new postdoctoral position to work on our project. If you want to contribute to the future of pharmaceutical R&D with cutting-edge technology, you can contact him directly! You can find the job advertisement here: https://apply.refline.ch/655298/4010/pub/1/index.html
28. July 2024 / 31. July 2024 by fass_wp_ad_hk_52
In spring 2024, the European Innovation Council (EIC) awarded a consortium of Swiss, German and French partners the prestigious EIC Transition grant amounting 2.5 M€. The FASS project (Fast and Accurate Solubility for Sustainability) starts June 1rst and will mature a disruptive solubility instrument towards its market entry which boosts productivity, safes resources and money […]
